Opportunities and challenges for innovative and equitable healthcare
David J. Ecker,Clarice D. Aiello,Joseph R. Arron,C. Frank Bennett,Amy Bernard,Xandra O. Breakefield,Timothy J. Broderick,Shawneequa L. Callier,Barry Canton,Janice S. Chen,C. Simone Fishburn,Banning Garrett,Sidney M. Hecht,Tobias Janowitz,Melinda Kliegman,Adrian Krainer,Chrystal U. Louis,Christopher Lowe,Alfica Sehgal,Yesim Tozan,Kevin J. Tracey,Fyodor Urnov,Daniel Wattendorf,Thomas W. Williams,Xuanhe Zhao,Michael R. Hayden
DOI: https://doi.org/10.1038/d41573-024-00032-4
IF: 112.288
2024-02-27
Nature Reviews Drug Discovery
Abstract:An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare. An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.
pharmacology & pharmacy,biotechnology & applied microbiology